Federated Hermes, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Federated Hermes, Inc.
- $43.9 Billion
- Q1 2025
A detailed history of Federated Hermes, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 585,115 shares of AMPH stock, worth $14.8 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
585,115
Previous 823,487
28.95%
Holding current value
$14.8 Million
Previous $30.6 Million
44.53%
% of portfolio
0.04%
Previous 0.07%
Shares
31 transactions
Others Institutions Holding AMPH
# of Institutions
258Shares Held
33.6MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$150 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$61.2 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$55.9 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$40.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$34.3 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.24B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...